Evdokia Anagnostou

Evdokia Anagnostou is a professor in the Department of Pediatrics at the University of Toronto, and is cross-appointed as pediatric neurologist and a senior clinician scientist at the Holland Bloorview Kids Rehabilitation Hospital in Toronto, Canada. She is a Tier 2 Canada Research Chair in Translational Therapeutics in Autism Spectrum Disorder.
Career.
Anagnostou is currently a professor in the Department of Pediatrics at the University of Toronto, and a senior clinician scientist at the Holland Bloorview Kids Rehabilitation Hospital in Toronto, Canada. Her research focuses on translating findings from basic research studies in the field of Autism Spectrum Disorder and related neurodevelopmental conditions into novel therapeutics. Upon realizing that patients with Autism Spectrum Disorder often have additional disorders (including intellectual disability, ADHD and OCD), Anagnostou and her colleagues launched the Province of Ontario Neurodevelopmental Disorders (POND) Network in 2013 to study multiple neurodevelopmental disorders (including Autism Spectrum Disorder) together. She is a principal investigator at POND, funded by the Ontario Brain Institute. POND co-investigators include Stephen W. Scherer.
Anagnostou was appointed as the inaugural Dr. Stuart D. Sims Chair in Autism at the Holland Bloorview Kids Rehabilitation Hospital in December 2016, and co-leads the Autism Research Centre within the institution. She was also appointed as a Canada Research Chair in Translational Therapeutics in Autism Spectrum Disorder in November 2017. She is an associate editor for Molecular Autism and Autism Research, and a grant reviewer for multiple international agencies
Anagnostou's research has been cited over 12545 times and has an h-index of 53. She regularly comments on Autism Spectrum Disorder as an expert on various Canadian media platforms.